New shot aims to control HIV in untreated patients
Disease control
Recruiting now
This early-stage study tests an injectable drug called LP-98 in 30 adults with HIV who have never taken antiretroviral therapy. The goal is to see if the drug can lower the amount of virus in the blood and improve immune cell counts. Participants will receive the injection and be…
Phase: PHASE1, PHASE2 • Sponsor: Shanxi Kangbao Biological Product Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC